nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenytoin—SCN5A—dilated cardiomyopathy	0.443	1	CbGaD
Phenytoin—CYP11B1—Spironolactone—dilated cardiomyopathy	0.212	0.546	CbGbCtD
Phenytoin—ABCC2—Spironolactone—dilated cardiomyopathy	0.0536	0.138	CbGbCtD
Phenytoin—ABCC2—Furosemide—dilated cardiomyopathy	0.0366	0.0943	CbGbCtD
Phenytoin—CYP2C8—Spironolactone—dilated cardiomyopathy	0.0258	0.0665	CbGbCtD
Phenytoin—ALB—Furosemide—dilated cardiomyopathy	0.0228	0.0588	CbGbCtD
Phenytoin—SCN5A—purkinje fiber—dilated cardiomyopathy	0.0214	0.396	CbGeAlD
Phenytoin—ABCB1—Lisinopril—dilated cardiomyopathy	0.0198	0.0511	CbGbCtD
Phenytoin—ABCB1—Spironolactone—dilated cardiomyopathy	0.0175	0.045	CbGbCtD
Phenytoin—SCN5A—endocardium—dilated cardiomyopathy	0.011	0.204	CbGeAlD
Phenytoin—SCN5A—sinoatrial node—dilated cardiomyopathy	0.0105	0.194	CbGeAlD
Phenytoin—CYP2C9—cardial valve—dilated cardiomyopathy	0.00552	0.102	CbGeAlD
Phenytoin—Hypertrichosis—Spironolactone—dilated cardiomyopathy	0.00276	0.0378	CcSEcCtD
Phenytoin—Pseudolymphoma—Lisinopril—dilated cardiomyopathy	0.00261	0.0358	CcSEcCtD
Phenytoin—Drug eruption—Spironolactone—dilated cardiomyopathy	0.00171	0.0234	CcSEcCtD
Phenytoin—Gastric irritation—Furosemide—dilated cardiomyopathy	0.00147	0.0202	CcSEcCtD
Phenytoin—Fosphenytoin—SCN5A—dilated cardiomyopathy	0.00138	0.605	CrCbGaD
Phenytoin—Atrial flutter—Lisinopril—dilated cardiomyopathy	0.00113	0.0154	CcSEcCtD
Phenytoin—Epigastric discomfort—Furosemide—dilated cardiomyopathy	0.00109	0.0149	CcSEcCtD
Phenytoin—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.00103	0.0141	CcSEcCtD
Phenytoin—Cramps of lower extremities—Spironolactone—dilated cardiomyopathy	0.000965	0.0132	CcSEcCtD
Phenytoin—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.00094	0.0129	CcSEcCtD
Phenytoin—Drug eruption—Furosemide—dilated cardiomyopathy	0.000929	0.0127	CcSEcCtD
Phenytoin—SCN5A—cardiac ventricle—dilated cardiomyopathy	0.000929	0.0172	CbGeAlD
Phenytoin—Lung infiltration—Lisinopril—dilated cardiomyopathy	0.000915	0.0125	CcSEcCtD
Phenytoin—SCN5A—myocardium—dilated cardiomyopathy	0.000874	0.0162	CbGeAlD
Phenytoin—Appetite absent—Lisinopril—dilated cardiomyopathy	0.000862	0.0118	CcSEcCtD
Phenytoin—Nephritis interstitial—Furosemide—dilated cardiomyopathy	0.000847	0.0116	CcSEcCtD
Phenytoin—SCN4A—heart—dilated cardiomyopathy	0.000787	0.0146	CbGeAlD
Phenytoin—Tubulointerstitial nephritis—Furosemide—dilated cardiomyopathy	0.000747	0.0102	CcSEcCtD
Phenytoin—Generalised oedema—Lisinopril—dilated cardiomyopathy	0.000721	0.00987	CcSEcCtD
Phenytoin—Ataxia—Spironolactone—dilated cardiomyopathy	0.000717	0.00981	CcSEcCtD
Phenytoin—Pelvic pain—Lisinopril—dilated cardiomyopathy	0.000705	0.00965	CcSEcCtD
Phenytoin—Injection site pain—Furosemide—dilated cardiomyopathy	0.0007	0.00958	CcSEcCtD
Phenytoin—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.000687	0.0094	CcSEcCtD
Phenytoin—Gastritis—Spironolactone—dilated cardiomyopathy	0.000675	0.00924	CcSEcCtD
Phenytoin—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.000653	0.00893	CcSEcCtD
Phenytoin—Carbamazepine—SCN5A—dilated cardiomyopathy	0.000625	0.275	CrCbGaD
Phenytoin—Hypocalcaemia—Furosemide—dilated cardiomyopathy	0.000625	0.00854	CcSEcCtD
Phenytoin—SCN3A—heart—dilated cardiomyopathy	0.000612	0.0113	CbGeAlD
Phenytoin—SCN5A—heart—dilated cardiomyopathy	0.00061	0.0113	CbGeAlD
Phenytoin—Drowsiness—Spironolactone—dilated cardiomyopathy	0.000588	0.00804	CcSEcCtD
Phenytoin—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.000583	0.00797	CcSEcCtD
Phenytoin—Haemoptysis—Lisinopril—dilated cardiomyopathy	0.00058	0.00793	CcSEcCtD
Phenytoin—Renal failure—Spironolactone—dilated cardiomyopathy	0.000578	0.00791	CcSEcCtD
Phenytoin—Ventricular fibrillation—Lisinopril—dilated cardiomyopathy	0.00056	0.00766	CcSEcCtD
Phenytoin—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.000549	0.00751	CcSEcCtD
Phenytoin—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.000525	0.00719	CcSEcCtD
Phenytoin—SCN5A—cardiac atrium—dilated cardiomyopathy	0.000522	0.00965	CbGeAlD
Phenytoin—Urine output increased—Furosemide—dilated cardiomyopathy	0.000517	0.00707	CcSEcCtD
Phenytoin—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.000499	0.00683	CcSEcCtD
Phenytoin—Mental disability—Furosemide—dilated cardiomyopathy	0.000496	0.00679	CcSEcCtD
Phenytoin—ALB—heart—dilated cardiomyopathy	0.000488	0.00904	CbGeAlD
Phenytoin—Accidental injury—Lisinopril—dilated cardiomyopathy	0.000485	0.00663	CcSEcCtD
Phenytoin—Chest discomfort—Lisinopril—dilated cardiomyopathy	0.000485	0.00663	CcSEcCtD
Phenytoin—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.000479	0.00656	CcSEcCtD
Phenytoin—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.000475	0.0065	CcSEcCtD
Phenytoin—Polyuria—Furosemide—dilated cardiomyopathy	0.000473	0.00647	CcSEcCtD
Phenytoin—Cough increased—Lisinopril—dilated cardiomyopathy	0.000469	0.00641	CcSEcCtD
Phenytoin—Oliguria—Lisinopril—dilated cardiomyopathy	0.000465	0.00637	CcSEcCtD
Phenytoin—Deafness—Furosemide—dilated cardiomyopathy	0.000464	0.00635	CcSEcCtD
Phenytoin—Leukocytosis—Lisinopril—dilated cardiomyopathy	0.000456	0.00624	CcSEcCtD
Phenytoin—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.000442	0.00604	CcSEcCtD
Phenytoin—Purpura—Furosemide—dilated cardiomyopathy	0.000431	0.00589	CcSEcCtD
Phenytoin—Pulmonary embolism—Lisinopril—dilated cardiomyopathy	0.000429	0.00587	CcSEcCtD
Phenytoin—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.000429	0.00587	CcSEcCtD
Phenytoin—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.000426	0.00583	CcSEcCtD
Phenytoin—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.000421	0.00577	CcSEcCtD
Phenytoin—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.000417	0.0057	CcSEcCtD
Phenytoin—Malaise—Spironolactone—dilated cardiomyopathy	0.000414	0.00567	CcSEcCtD
Phenytoin—Leukopenia—Spironolactone—dilated cardiomyopathy	0.000411	0.00563	CcSEcCtD
Phenytoin—Fluid retention—Lisinopril—dilated cardiomyopathy	0.000407	0.00557	CcSEcCtD
Phenytoin—Photophobia—Lisinopril—dilated cardiomyopathy	0.000403	0.00551	CcSEcCtD
Phenytoin—Irritability—Furosemide—dilated cardiomyopathy	0.000396	0.00542	CcSEcCtD
Phenytoin—Urinary retention—Furosemide—dilated cardiomyopathy	0.000395	0.0054	CcSEcCtD
Phenytoin—Discomfort—Spironolactone—dilated cardiomyopathy	0.000386	0.00529	CcSEcCtD
Phenytoin—Dehydration—Furosemide—dilated cardiomyopathy	0.000386	0.00528	CcSEcCtD
Phenytoin—Orthostatic hypotension—Furosemide—dilated cardiomyopathy	0.000379	0.00519	CcSEcCtD
Phenytoin—Confusional state—Spironolactone—dilated cardiomyopathy	0.000378	0.00517	CcSEcCtD
Phenytoin—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.000378	0.00517	CcSEcCtD
Phenytoin—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.000375	0.00513	CcSEcCtD
Phenytoin—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.000374	0.00511	CcSEcCtD
Phenytoin—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.000367	0.00502	CcSEcCtD
Phenytoin—Muscular weakness—Furosemide—dilated cardiomyopathy	0.000366	0.00501	CcSEcCtD
Phenytoin—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.000356	0.00487	CcSEcCtD
Phenytoin—Eosinophilia—Furosemide—dilated cardiomyopathy	0.000355	0.00486	CcSEcCtD
Phenytoin—Injury—Lisinopril—dilated cardiomyopathy	0.000339	0.00463	CcSEcCtD
Phenytoin—Somnolence—Spironolactone—dilated cardiomyopathy	0.000333	0.00456	CcSEcCtD
Phenytoin—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.000327	0.00448	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.000324	0.00443	CcSEcCtD
Phenytoin—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.000324	0.00443	CcSEcCtD
Phenytoin—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.000322	0.0044	CcSEcCtD
Phenytoin—Drowsiness—Furosemide—dilated cardiomyopathy	0.00032	0.00438	CcSEcCtD
Phenytoin—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.000317	0.00434	CcSEcCtD
Phenytoin—Renal failure—Furosemide—dilated cardiomyopathy	0.000314	0.0043	CcSEcCtD
Phenytoin—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.000311	0.00426	CcSEcCtD
Phenytoin—Diplopia—Lisinopril—dilated cardiomyopathy	0.000311	0.00426	CcSEcCtD
Phenytoin—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.000309	0.00423	CcSEcCtD
Phenytoin—CYP2B6—heart—dilated cardiomyopathy	0.000308	0.0057	CbGeAlD
Phenytoin—Sweating—Furosemide—dilated cardiomyopathy	0.000307	0.00419	CcSEcCtD
Phenytoin—CYP2C9—heart—dilated cardiomyopathy	0.000305	0.00564	CbGeAlD
Phenytoin—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.000302	0.00414	CcSEcCtD
Phenytoin—Face oedema—Lisinopril—dilated cardiomyopathy	0.000301	0.00411	CcSEcCtD
Phenytoin—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.000298	0.00408	CcSEcCtD
Phenytoin—Urticaria—Spironolactone—dilated cardiomyopathy	0.000298	0.00407	CcSEcCtD
Phenytoin—Irritability—Lisinopril—dilated cardiomyopathy	0.000297	0.00407	CcSEcCtD
Phenytoin—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.000296	0.00405	CcSEcCtD
Phenytoin—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.000296	0.00405	CcSEcCtD
Phenytoin—Ataxia—Lisinopril—dilated cardiomyopathy	0.000293	0.00401	CcSEcCtD
Phenytoin—Dehydration—Lisinopril—dilated cardiomyopathy	0.00029	0.00396	CcSEcCtD
Phenytoin—Orthostatic hypotension—Lisinopril—dilated cardiomyopathy	0.000284	0.00389	CcSEcCtD
Phenytoin—Breast disorder—Lisinopril—dilated cardiomyopathy	0.000281	0.00385	CcSEcCtD
Phenytoin—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00028	0.00384	CcSEcCtD
Phenytoin—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.000276	0.00378	CcSEcCtD
Phenytoin—Gastritis—Lisinopril—dilated cardiomyopathy	0.000276	0.00377	CcSEcCtD
Phenytoin—Diphenhydramine—SLC22A5—dilated cardiomyopathy	0.000274	0.12	CrCbGaD
Phenytoin—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.000271	0.00371	CcSEcCtD
Phenytoin—Asthma—Lisinopril—dilated cardiomyopathy	0.000269	0.00368	CcSEcCtD
Phenytoin—Influenza—Lisinopril—dilated cardiomyopathy	0.000269	0.00368	CcSEcCtD
Phenytoin—Tinnitus—Furosemide—dilated cardiomyopathy	0.000268	0.00366	CcSEcCtD
Phenytoin—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.000266	0.00365	CcSEcCtD
Phenytoin—Pruritus—Spironolactone—dilated cardiomyopathy	0.000265	0.00363	CcSEcCtD
Phenytoin—Immune system disorder—Furosemide—dilated cardiomyopathy	0.000259	0.00355	CcSEcCtD
Phenytoin—Bronchitis—Lisinopril—dilated cardiomyopathy	0.000259	0.00354	CcSEcCtD
Phenytoin—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.000257	0.00351	CcSEcCtD
Phenytoin—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.000256	0.0035	CcSEcCtD
Phenytoin—Dysuria—Lisinopril—dilated cardiomyopathy	0.000252	0.00344	CcSEcCtD
Phenytoin—Dizziness—Spironolactone—dilated cardiomyopathy	0.000248	0.00339	CcSEcCtD
Phenytoin—Flatulence—Furosemide—dilated cardiomyopathy	0.000246	0.00337	CcSEcCtD
Phenytoin—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.000246	0.00336	CcSEcCtD
Phenytoin—Dysgeusia—Furosemide—dilated cardiomyopathy	0.000245	0.00335	CcSEcCtD
Phenytoin—Weight decreased—Lisinopril—dilated cardiomyopathy	0.000243	0.00333	CcSEcCtD
Phenytoin—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.000243	0.00332	CcSEcCtD
Phenytoin—Pneumonia—Lisinopril—dilated cardiomyopathy	0.000241	0.0033	CcSEcCtD
Phenytoin—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00024	0.00329	CcSEcCtD
Phenytoin—Vomiting—Spironolactone—dilated cardiomyopathy	0.000238	0.00326	CcSEcCtD
Phenytoin—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.000238	0.00325	CcSEcCtD
Phenytoin—Rash—Spironolactone—dilated cardiomyopathy	0.000236	0.00323	CcSEcCtD
Phenytoin—Dermatitis—Spironolactone—dilated cardiomyopathy	0.000236	0.00323	CcSEcCtD
Phenytoin—Renal failure—Lisinopril—dilated cardiomyopathy	0.000236	0.00323	CcSEcCtD
Phenytoin—Headache—Spironolactone—dilated cardiomyopathy	0.000235	0.00321	CcSEcCtD
Phenytoin—Anaemia—Furosemide—dilated cardiomyopathy	0.000231	0.00316	CcSEcCtD
Phenytoin—Sweating—Lisinopril—dilated cardiomyopathy	0.00023	0.00315	CcSEcCtD
Phenytoin—Agitation—Furosemide—dilated cardiomyopathy	0.00023	0.00314	CcSEcCtD
Phenytoin—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.000227	0.0031	CcSEcCtD
Phenytoin—Epistaxis—Lisinopril—dilated cardiomyopathy	0.000226	0.0031	CcSEcCtD
Phenytoin—Sinusitis—Lisinopril—dilated cardiomyopathy	0.000225	0.00308	CcSEcCtD
Phenytoin—Vertigo—Furosemide—dilated cardiomyopathy	0.000225	0.00307	CcSEcCtD
Phenytoin—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.000224	0.00306	CcSEcCtD
Phenytoin—Leukopenia—Furosemide—dilated cardiomyopathy	0.000224	0.00306	CcSEcCtD
Phenytoin—Nausea—Spironolactone—dilated cardiomyopathy	0.000223	0.00305	CcSEcCtD
Phenytoin—Bradycardia—Lisinopril—dilated cardiomyopathy	0.000219	0.003	CcSEcCtD
Phenytoin—Rhinitis—Lisinopril—dilated cardiomyopathy	0.000216	0.00295	CcSEcCtD
Phenytoin—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.000214	0.00293	CcSEcCtD
Phenytoin—Dry mouth—Furosemide—dilated cardiomyopathy	0.000208	0.00285	CcSEcCtD
Phenytoin—Confusional state—Furosemide—dilated cardiomyopathy	0.000206	0.00281	CcSEcCtD
Phenytoin—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.000204	0.00279	CcSEcCtD
Phenytoin—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.000204	0.00279	CcSEcCtD
Phenytoin—Tinnitus—Lisinopril—dilated cardiomyopathy	0.000201	0.00275	CcSEcCtD
Phenytoin—Shock—Furosemide—dilated cardiomyopathy	0.000201	0.00275	CcSEcCtD
Phenytoin—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.0002	0.00274	CcSEcCtD
Phenytoin—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.0002	0.00273	CcSEcCtD
Phenytoin—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.000197	0.0027	CcSEcCtD
Phenytoin—Anorexia—Furosemide—dilated cardiomyopathy	0.000194	0.00266	CcSEcCtD
Phenytoin—Chills—Lisinopril—dilated cardiomyopathy	0.000193	0.00264	CcSEcCtD
Phenytoin—Hypotension—Furosemide—dilated cardiomyopathy	0.000191	0.00261	CcSEcCtD
Phenytoin—Flatulence—Lisinopril—dilated cardiomyopathy	0.000185	0.00253	CcSEcCtD
Phenytoin—Tension—Lisinopril—dilated cardiomyopathy	0.000184	0.00252	CcSEcCtD
Phenytoin—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.000184	0.00251	CcSEcCtD
Phenytoin—Paraesthesia—Furosemide—dilated cardiomyopathy	0.000183	0.00251	CcSEcCtD
Phenytoin—Nervousness—Lisinopril—dilated cardiomyopathy	0.000182	0.00249	CcSEcCtD
Phenytoin—Back pain—Lisinopril—dilated cardiomyopathy	0.000181	0.00248	CcSEcCtD
Phenytoin—Somnolence—Furosemide—dilated cardiomyopathy	0.000181	0.00248	CcSEcCtD
Phenytoin—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00018	0.00247	CcSEcCtD
Phenytoin—Decreased appetite—Furosemide—dilated cardiomyopathy	0.000177	0.00243	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.000176	0.00241	CcSEcCtD
Phenytoin—Fatigue—Furosemide—dilated cardiomyopathy	0.000176	0.00241	CcSEcCtD
Phenytoin—Tremor—Lisinopril—dilated cardiomyopathy	0.000176	0.0024	CcSEcCtD
Phenytoin—Constipation—Furosemide—dilated cardiomyopathy	0.000174	0.00239	CcSEcCtD
Phenytoin—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.000174	0.00238	CcSEcCtD
Phenytoin—Anaemia—Lisinopril—dilated cardiomyopathy	0.000173	0.00237	CcSEcCtD
Phenytoin—Malaise—Lisinopril—dilated cardiomyopathy	0.000169	0.00231	CcSEcCtD
Phenytoin—Vertigo—Lisinopril—dilated cardiomyopathy	0.000168	0.0023	CcSEcCtD
Phenytoin—Syncope—Lisinopril—dilated cardiomyopathy	0.000168	0.0023	CcSEcCtD
Phenytoin—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.000168	0.0023	CcSEcCtD
Phenytoin—Leukopenia—Lisinopril—dilated cardiomyopathy	0.000168	0.0023	CcSEcCtD
Phenytoin—Palpitations—Lisinopril—dilated cardiomyopathy	0.000166	0.00227	CcSEcCtD
Phenytoin—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.000165	0.00225	CcSEcCtD
Phenytoin—ABCB1—heart—dilated cardiomyopathy	0.000165	0.00304	CbGeAlD
Phenytoin—Cough—Lisinopril—dilated cardiomyopathy	0.000164	0.00224	CcSEcCtD
Phenytoin—Urticaria—Furosemide—dilated cardiomyopathy	0.000162	0.00222	CcSEcCtD
Phenytoin—Body temperature increased—Furosemide—dilated cardiomyopathy	0.000161	0.00221	CcSEcCtD
Phenytoin—Chest pain—Lisinopril—dilated cardiomyopathy	0.00016	0.00218	CcSEcCtD
Phenytoin—Myalgia—Lisinopril—dilated cardiomyopathy	0.00016	0.00218	CcSEcCtD
Phenytoin—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00016	0.00218	CcSEcCtD
Phenytoin—Discomfort—Lisinopril—dilated cardiomyopathy	0.000158	0.00216	CcSEcCtD
Phenytoin—Dry mouth—Lisinopril—dilated cardiomyopathy	0.000156	0.00214	CcSEcCtD
Phenytoin—Confusional state—Lisinopril—dilated cardiomyopathy	0.000154	0.00211	CcSEcCtD
Phenytoin—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000153	0.00209	CcSEcCtD
Phenytoin—Infection—Lisinopril—dilated cardiomyopathy	0.000152	0.00208	CcSEcCtD
Phenytoin—Shock—Lisinopril—dilated cardiomyopathy	0.000151	0.00206	CcSEcCtD
Phenytoin—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00015	0.00206	CcSEcCtD
Phenytoin—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00015	0.00205	CcSEcCtD
Phenytoin—Tachycardia—Lisinopril—dilated cardiomyopathy	0.000149	0.00204	CcSEcCtD
Phenytoin—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.000148	0.00202	CcSEcCtD
Phenytoin—Asthenia—Furosemide—dilated cardiomyopathy	0.000146	0.002	CcSEcCtD
Phenytoin—Anorexia—Lisinopril—dilated cardiomyopathy	0.000146	0.002	CcSEcCtD
Phenytoin—Pruritus—Furosemide—dilated cardiomyopathy	0.000144	0.00197	CcSEcCtD
Phenytoin—SLCO1C1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000144	0.00361	CbGpPWpGaD
Phenytoin—Hypotension—Lisinopril—dilated cardiomyopathy	0.000143	0.00196	CcSEcCtD
Phenytoin—CYP11B1—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000142	0.00356	CbGpPWpGaD
Phenytoin—SLCO1C1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00014	0.00351	CbGpPWpGaD
Phenytoin—SLCO1C1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00014	0.00351	CbGpPWpGaD
Phenytoin—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00014	0.00191	CcSEcCtD
Phenytoin—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.000139	0.00191	CcSEcCtD
Phenytoin—Insomnia—Lisinopril—dilated cardiomyopathy	0.000138	0.00189	CcSEcCtD
Phenytoin—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.000137	0.00188	CcSEcCtD
Phenytoin—ALB—Platelet degranulation—ACTN2—dilated cardiomyopathy	0.000137	0.00344	CbGpPWpGaD
Phenytoin—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.000136	0.00187	CcSEcCtD
Phenytoin—Somnolence—Lisinopril—dilated cardiomyopathy	0.000136	0.00186	CcSEcCtD
Phenytoin—Dizziness—Furosemide—dilated cardiomyopathy	0.000135	0.00185	CcSEcCtD
Phenytoin—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.000135	0.00184	CcSEcCtD
Phenytoin—SCN5A—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.000134	0.00336	CbGpPWpGaD
Phenytoin—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000133	0.00182	CcSEcCtD
Phenytoin—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.000132	0.00181	CcSEcCtD
Phenytoin—Fatigue—Lisinopril—dilated cardiomyopathy	0.000132	0.00181	CcSEcCtD
Phenytoin—Constipation—Lisinopril—dilated cardiomyopathy	0.000131	0.00179	CcSEcCtD
Phenytoin—ALB—Response to elevated platelet cytosolic Ca2+—ACTN2—dilated cardiomyopathy	0.00013	0.00328	CbGpPWpGaD
Phenytoin—SLCO1C1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00013	0.00327	CbGpPWpGaD
Phenytoin—SCN9A—Axon guidance—PSEN2—dilated cardiomyopathy	0.00013	0.00326	CbGpPWpGaD
Phenytoin—Vomiting—Furosemide—dilated cardiomyopathy	0.00013	0.00177	CcSEcCtD
Phenytoin—Rash—Furosemide—dilated cardiomyopathy	0.000129	0.00176	CcSEcCtD
Phenytoin—Dermatitis—Furosemide—dilated cardiomyopathy	0.000128	0.00176	CcSEcCtD
Phenytoin—Headache—Furosemide—dilated cardiomyopathy	0.000128	0.00175	CcSEcCtD
Phenytoin—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.000126	0.00173	CcSEcCtD
Phenytoin—SCN3A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000124	0.00312	CbGpPWpGaD
Phenytoin—Urticaria—Lisinopril—dilated cardiomyopathy	0.000122	0.00166	CcSEcCtD
Phenytoin—Nausea—Furosemide—dilated cardiomyopathy	0.000121	0.00166	CcSEcCtD
Phenytoin—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000121	0.00166	CcSEcCtD
Phenytoin—SCN4A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000119	0.003	CbGpPWpGaD
Phenytoin—SCN2A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000119	0.003	CbGpPWpGaD
Phenytoin—ALB—Platelet degranulation—VCL—dilated cardiomyopathy	0.000116	0.00292	CbGpPWpGaD
Phenytoin—SCN1A—Axon guidance—PSEN2—dilated cardiomyopathy	0.000115	0.00289	CbGpPWpGaD
Phenytoin—SCN8A—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000115	0.00288	CbGpPWpGaD
Phenytoin—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000113	0.00154	CcSEcCtD
Phenytoin—ALB—Response to elevated platelet cytosolic Ca2+—VCL—dilated cardiomyopathy	0.000111	0.00279	CbGpPWpGaD
Phenytoin—Asthenia—Lisinopril—dilated cardiomyopathy	0.00011	0.0015	CcSEcCtD
Phenytoin—Pruritus—Lisinopril—dilated cardiomyopathy	0.000108	0.00148	CcSEcCtD
Phenytoin—SCN5A—L1CAM interactions—RAC1—dilated cardiomyopathy	0.000108	0.0027	CbGpPWpGaD
Phenytoin—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000105	0.00143	CcSEcCtD
Phenytoin—Dizziness—Lisinopril—dilated cardiomyopathy	0.000101	0.00138	CcSEcCtD
Phenytoin—SCN8A—Axon guidance—ITGB1—dilated cardiomyopathy	0.0001	0.00252	CbGpPWpGaD
Phenytoin—Vomiting—Lisinopril—dilated cardiomyopathy	9.73e-05	0.00133	CcSEcCtD
Phenytoin—SCN8A—L1CAM interactions—EGFR—dilated cardiomyopathy	9.72e-05	0.00244	CbGpPWpGaD
Phenytoin—Rash—Lisinopril—dilated cardiomyopathy	9.65e-05	0.00132	CcSEcCtD
Phenytoin—Dermatitis—Lisinopril—dilated cardiomyopathy	9.64e-05	0.00132	CcSEcCtD
Phenytoin—Headache—Lisinopril—dilated cardiomyopathy	9.59e-05	0.00131	CcSEcCtD
Phenytoin—SCN5A—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	9.58e-05	0.00241	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—PSEN2—dilated cardiomyopathy	9.27e-05	0.00233	CbGpPWpGaD
Phenytoin—CYP11B1—Corticotropin-releasing hormone—RAF1—dilated cardiomyopathy	9.09e-05	0.00228	CbGpPWpGaD
Phenytoin—Nausea—Lisinopril—dilated cardiomyopathy	9.09e-05	0.00124	CcSEcCtD
Phenytoin—SCN3A—Developmental Biology—PSEN2—dilated cardiomyopathy	8.86e-05	0.00223	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—PSEN2—dilated cardiomyopathy	8.52e-05	0.00214	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—PSEN2—dilated cardiomyopathy	8.52e-05	0.00214	CbGpPWpGaD
Phenytoin—ALB—Binding and Uptake of Ligands by Scavenger Receptors—CD36—dilated cardiomyopathy	8.51e-05	0.00214	CbGpPWpGaD
Phenytoin—SCN5A—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	8.31e-05	0.00209	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—PSEN2—dilated cardiomyopathy	8.21e-05	0.00206	CbGpPWpGaD
Phenytoin—SCN9A—Axon guidance—ITGB1—dilated cardiomyopathy	8.12e-05	0.00204	CbGpPWpGaD
Phenytoin—SCN5A—Axon guidance—PSEN2—dilated cardiomyopathy	8.09e-05	0.00203	CbGpPWpGaD
Phenytoin—SCN8A—Axon guidance—RAC1—dilated cardiomyopathy	8.08e-05	0.00203	CbGpPWpGaD
Phenytoin—SCN9A—L1CAM interactions—EGFR—dilated cardiomyopathy	7.86e-05	0.00197	CbGpPWpGaD
Phenytoin—SCN3A—Axon guidance—ITGB1—dilated cardiomyopathy	7.77e-05	0.00195	CbGpPWpGaD
Phenytoin—ALB—Vitamin B12 Metabolism—SOD2—dilated cardiomyopathy	7.69e-05	0.00193	CbGpPWpGaD
Phenytoin—SCN3A—L1CAM interactions—EGFR—dilated cardiomyopathy	7.52e-05	0.00189	CbGpPWpGaD
Phenytoin—CYP2C8—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	7.5e-05	0.00188	CbGpPWpGaD
Phenytoin—SCN2A—Axon guidance—ITGB1—dilated cardiomyopathy	7.47e-05	0.00188	CbGpPWpGaD
Phenytoin—SCN4A—Axon guidance—ITGB1—dilated cardiomyopathy	7.47e-05	0.00188	CbGpPWpGaD
Phenytoin—SCN2A—L1CAM interactions—EGFR—dilated cardiomyopathy	7.22e-05	0.00181	CbGpPWpGaD
Phenytoin—SCN4A—L1CAM interactions—EGFR—dilated cardiomyopathy	7.22e-05	0.00181	CbGpPWpGaD
Phenytoin—SCN1A—Axon guidance—ITGB1—dilated cardiomyopathy	7.2e-05	0.00181	CbGpPWpGaD
Phenytoin—SCN8A—Developmental Biology—ITGB1—dilated cardiomyopathy	7.17e-05	0.0018	CbGpPWpGaD
Phenytoin—ALB—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	7e-05	0.00176	CbGpPWpGaD
Phenytoin—SCN1A—L1CAM interactions—EGFR—dilated cardiomyopathy	6.96e-05	0.00175	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—dilated cardiomyopathy	6.71e-05	0.00169	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—ANKRD1—dilated cardiomyopathy	6.71e-05	0.00168	CbGpPWpGaD
Phenytoin—CYP2C19—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	6.69e-05	0.00168	CbGpPWpGaD
Phenytoin—SCN9A—Axon guidance—RAC1—dilated cardiomyopathy	6.53e-05	0.00164	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—TAZ—dilated cardiomyopathy	6.31e-05	0.00158	CbGpPWpGaD
Phenytoin—ALB—Folate Metabolism—SOD2—dilated cardiomyopathy	6.26e-05	0.00157	CbGpPWpGaD
Phenytoin—SCN3A—Axon guidance—RAC1—dilated cardiomyopathy	6.25e-05	0.00157	CbGpPWpGaD
Phenytoin—SCN8A—Developmental Biology—CD36—dilated cardiomyopathy	6.11e-05	0.00154	CbGpPWpGaD
Phenytoin—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	6.1e-05	0.00153	CbGpPWpGaD
Phenytoin—ALB—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	6.07e-05	0.00153	CbGpPWpGaD
Phenytoin—SCN2A—Axon guidance—RAC1—dilated cardiomyopathy	6e-05	0.00151	CbGpPWpGaD
Phenytoin—SCN4A—Axon guidance—RAC1—dilated cardiomyopathy	6e-05	0.00151	CbGpPWpGaD
Phenytoin—ALB—SLC-mediated transmembrane transport—SLC22A5—dilated cardiomyopathy	5.98e-05	0.0015	CbGpPWpGaD
Phenytoin—ALB—Folate Metabolism—GPX1—dilated cardiomyopathy	5.97e-05	0.0015	CbGpPWpGaD
Phenytoin—ABCC2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	5.82e-05	0.00146	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—ITGB1—dilated cardiomyopathy	5.8e-05	0.00146	CbGpPWpGaD
Phenytoin—SCN1A—Axon guidance—RAC1—dilated cardiomyopathy	5.79e-05	0.00145	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—PSEN2—dilated cardiomyopathy	5.77e-05	0.00145	CbGpPWpGaD
Phenytoin—SCN8A—Developmental Biology—RAC1—dilated cardiomyopathy	5.76e-05	0.00145	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—SDHA—dilated cardiomyopathy	5.7e-05	0.00143	CbGpPWpGaD
Phenytoin—ABCC2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	5.67e-05	0.00142	CbGpPWpGaD
Phenytoin—ABCC2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	5.67e-05	0.00142	CbGpPWpGaD
Phenytoin—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	5.65e-05	0.00142	CbGpPWpGaD
Phenytoin—SCN3A—Developmental Biology—ITGB1—dilated cardiomyopathy	5.55e-05	0.00139	CbGpPWpGaD
Phenytoin—SCN8A—Axon guidance—RAF1—dilated cardiomyopathy	5.35e-05	0.00134	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—ITGB1—dilated cardiomyopathy	5.33e-05	0.00134	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—ITGB1—dilated cardiomyopathy	5.33e-05	0.00134	CbGpPWpGaD
Phenytoin—ABCC2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	5.27e-05	0.00132	CbGpPWpGaD
Phenytoin—ALB—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	5.16e-05	0.0013	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—ITGB1—dilated cardiomyopathy	5.14e-05	0.00129	CbGpPWpGaD
Phenytoin—SCN5A—Axon guidance—ITGB1—dilated cardiomyopathy	5.06e-05	0.00127	CbGpPWpGaD
Phenytoin—ALB—Platelet degranulation—CD36—dilated cardiomyopathy	4.99e-05	0.00125	CbGpPWpGaD
Phenytoin—ALB—Selenium Micronutrient Network—SOD2—dilated cardiomyopathy	4.97e-05	0.00125	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—ANKRD1—dilated cardiomyopathy	4.96e-05	0.00125	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—CD36—dilated cardiomyopathy	4.95e-05	0.00124	CbGpPWpGaD
Phenytoin—SCN5A—L1CAM interactions—EGFR—dilated cardiomyopathy	4.9e-05	0.00123	CbGpPWpGaD
Phenytoin—ALB—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	4.75e-05	0.00119	CbGpPWpGaD
Phenytoin—ALB—Selenium Micronutrient Network—GPX1—dilated cardiomyopathy	4.74e-05	0.00119	CbGpPWpGaD
Phenytoin—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	4.73e-05	0.00119	CbGpPWpGaD
Phenytoin—SCN3A—Developmental Biology—CD36—dilated cardiomyopathy	4.73e-05	0.00119	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—TAZ—dilated cardiomyopathy	4.67e-05	0.00117	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—RAC1—dilated cardiomyopathy	4.66e-05	0.00117	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	4.64e-05	0.00117	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	4.61e-05	0.00116	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—CD36—dilated cardiomyopathy	4.54e-05	0.00114	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—CD36—dilated cardiomyopathy	4.54e-05	0.00114	CbGpPWpGaD
Phenytoin—SCN3A—Developmental Biology—RAC1—dilated cardiomyopathy	4.46e-05	0.00112	CbGpPWpGaD
Phenytoin—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	4.4e-05	0.0011	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—CD36—dilated cardiomyopathy	4.38e-05	0.0011	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	4.36e-05	0.0011	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	4.34e-05	0.00109	CbGpPWpGaD
Phenytoin—SCN9A—Axon guidance—RAF1—dilated cardiomyopathy	4.33e-05	0.00109	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—RAC1—dilated cardiomyopathy	4.28e-05	0.00108	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—RAC1—dilated cardiomyopathy	4.28e-05	0.00108	CbGpPWpGaD
Phenytoin—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	4.24e-05	0.00107	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—SDHA—dilated cardiomyopathy	4.22e-05	0.00106	CbGpPWpGaD
Phenytoin—SCN3A—Axon guidance—RAF1—dilated cardiomyopathy	4.14e-05	0.00104	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	4.14e-05	0.00104	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—RAC1—dilated cardiomyopathy	4.13e-05	0.00104	CbGpPWpGaD
Phenytoin—SCN5A—Axon guidance—RAC1—dilated cardiomyopathy	4.07e-05	0.00102	CbGpPWpGaD
Phenytoin—SCN2A—Axon guidance—RAF1—dilated cardiomyopathy	3.98e-05	0.001	CbGpPWpGaD
Phenytoin—SCN4A—Axon guidance—RAF1—dilated cardiomyopathy	3.98e-05	0.001	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	3.89e-05	0.000978	CbGpPWpGaD
Phenytoin—SCN1A—Axon guidance—RAF1—dilated cardiomyopathy	3.84e-05	0.000964	CbGpPWpGaD
Phenytoin—SCN8A—Developmental Biology—RAF1—dilated cardiomyopathy	3.82e-05	0.00096	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	3.78e-05	0.000949	CbGpPWpGaD
Phenytoin—SCN8A—Axon guidance—EGFR—dilated cardiomyopathy	3.67e-05	0.000922	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—ITGB1—dilated cardiomyopathy	3.61e-05	0.000907	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—TTN—dilated cardiomyopathy	3.61e-05	0.000907	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	3.55e-05	0.000892	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	3.48e-05	0.000874	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	3.39e-05	0.000851	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—ANKRD1—dilated cardiomyopathy	3.3e-05	0.000829	CbGpPWpGaD
Phenytoin—SCN5A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	3.16e-05	0.000794	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—ACTN2—dilated cardiomyopathy	3.13e-05	0.000786	CbGpPWpGaD
Phenytoin—ALB—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	3.13e-05	0.000785	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—TAZ—dilated cardiomyopathy	3.1e-05	0.000779	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—RAF1—dilated cardiomyopathy	3.09e-05	0.000776	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—CD36—dilated cardiomyopathy	3.08e-05	0.000774	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	3.05e-05	0.000766	CbGpPWpGaD
Phenytoin—ALB—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	3.04e-05	0.000764	CbGpPWpGaD
Phenytoin—ALB—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	3.04e-05	0.000764	CbGpPWpGaD
Phenytoin—SCN9A—Axon guidance—EGFR—dilated cardiomyopathy	2.97e-05	0.000746	CbGpPWpGaD
Phenytoin—SCN3A—Developmental Biology—RAF1—dilated cardiomyopathy	2.96e-05	0.000742	CbGpPWpGaD
Phenytoin—ALB—Vitamin B12 Metabolism—TNF—dilated cardiomyopathy	2.92e-05	0.000733	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—RAC1—dilated cardiomyopathy	2.9e-05	0.000729	CbGpPWpGaD
Phenytoin—SCN3A—Axon guidance—EGFR—dilated cardiomyopathy	2.84e-05	0.000713	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—RAF1—dilated cardiomyopathy	2.84e-05	0.000713	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—RAF1—dilated cardiomyopathy	2.84e-05	0.000713	CbGpPWpGaD
Phenytoin—SLCO1C1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	2.84e-05	0.000712	CbGpPWpGaD
Phenytoin—ALB—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	2.83e-05	0.00071	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—SDHA—dilated cardiomyopathy	2.81e-05	0.000705	CbGpPWpGaD
Phenytoin—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	2.74e-05	0.000688	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—RAF1—dilated cardiomyopathy	2.74e-05	0.000688	CbGpPWpGaD
Phenytoin—SCN2A—Axon guidance—EGFR—dilated cardiomyopathy	2.73e-05	0.000685	CbGpPWpGaD
Phenytoin—SCN4A—Axon guidance—EGFR—dilated cardiomyopathy	2.73e-05	0.000685	CbGpPWpGaD
Phenytoin—SCN5A—Axon guidance—RAF1—dilated cardiomyopathy	2.7e-05	0.000678	CbGpPWpGaD
Phenytoin—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	2.66e-05	0.000669	CbGpPWpGaD
Phenytoin—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	2.66e-05	0.000669	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—VCL—dilated cardiomyopathy	2.66e-05	0.000669	CbGpPWpGaD
Phenytoin—SCN1A—Axon guidance—EGFR—dilated cardiomyopathy	2.63e-05	0.000661	CbGpPWpGaD
Phenytoin—SCN8A—Developmental Biology—EGFR—dilated cardiomyopathy	2.62e-05	0.000658	CbGpPWpGaD
Phenytoin—SCN8A—Developmental Biology—TNF—dilated cardiomyopathy	2.5e-05	0.000627	CbGpPWpGaD
Phenytoin—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	2.48e-05	0.000622	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—ANKRD1—dilated cardiomyopathy	2.44e-05	0.000613	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—ANKRD1—dilated cardiomyopathy	2.39e-05	0.000599	CbGpPWpGaD
Phenytoin—ALB—Folate Metabolism—TNF—dilated cardiomyopathy	2.37e-05	0.000596	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—TAZ—dilated cardiomyopathy	2.29e-05	0.000576	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—TAZ—dilated cardiomyopathy	2.24e-05	0.000563	CbGpPWpGaD
Phenytoin—ALB—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	2.21e-05	0.000555	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	2.17e-05	0.000545	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—EGFR—dilated cardiomyopathy	2.12e-05	0.000532	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	2.09e-05	0.000526	CbGpPWpGaD
Phenytoin—ALB—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	2.08e-05	0.000523	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—SDHA—dilated cardiomyopathy	2.08e-05	0.000521	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	2.07e-05	0.000519	CbGpPWpGaD
Phenytoin—ALB—Metabolism—ANKRD1—dilated cardiomyopathy	2.05e-05	0.000516	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	2.05e-05	0.000515	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—SDHA—dilated cardiomyopathy	2.03e-05	0.00051	CbGpPWpGaD
Phenytoin—SCN3A—Developmental Biology—EGFR—dilated cardiomyopathy	2.03e-05	0.000509	CbGpPWpGaD
Phenytoin—SCN9A—Developmental Biology—TNF—dilated cardiomyopathy	2.02e-05	0.000507	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—EGFR—dilated cardiomyopathy	1.95e-05	0.000489	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—EGFR—dilated cardiomyopathy	1.95e-05	0.000489	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	1.94e-05	0.000488	CbGpPWpGaD
Phenytoin—ALB—Metabolism—TAZ—dilated cardiomyopathy	1.93e-05	0.000485	CbGpPWpGaD
Phenytoin—SCN3A—Developmental Biology—TNF—dilated cardiomyopathy	1.93e-05	0.000485	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—RAF1—dilated cardiomyopathy	1.93e-05	0.000484	CbGpPWpGaD
Phenytoin—ALB—Selenium Micronutrient Network—TNF—dilated cardiomyopathy	1.89e-05	0.000474	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—EGFR—dilated cardiomyopathy	1.88e-05	0.000472	CbGpPWpGaD
Phenytoin—SCN2A—Developmental Biology—TNF—dilated cardiomyopathy	1.85e-05	0.000466	CbGpPWpGaD
Phenytoin—SCN4A—Developmental Biology—TNF—dilated cardiomyopathy	1.85e-05	0.000466	CbGpPWpGaD
Phenytoin—SCN5A—Axon guidance—EGFR—dilated cardiomyopathy	1.85e-05	0.000465	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—ANKRD1—dilated cardiomyopathy	1.84e-05	0.000463	CbGpPWpGaD
Phenytoin—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	1.8e-05	0.000452	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	1.8e-05	0.000452	CbGpPWpGaD
Phenytoin—SCN1A—Developmental Biology—TNF—dilated cardiomyopathy	1.79e-05	0.000449	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	1.76e-05	0.000441	CbGpPWpGaD
Phenytoin—ALB—Metabolism—SDHA—dilated cardiomyopathy	1.75e-05	0.000439	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—TAZ—dilated cardiomyopathy	1.73e-05	0.000436	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	1.69e-05	0.000425	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	1.68e-05	0.000422	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	1.58e-05	0.000397	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—SDHA—dilated cardiomyopathy	1.57e-05	0.000394	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—GPX1—dilated cardiomyopathy	1.55e-05	0.000389	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	1.53e-05	0.000384	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—CD36—dilated cardiomyopathy	1.51e-05	0.000379	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	1.43e-05	0.000359	CbGpPWpGaD
Phenytoin—ALB—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	1.38e-05	0.000347	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	1.36e-05	0.000342	CbGpPWpGaD
Phenytoin—CYP11B1—Metabolism—AGT—dilated cardiomyopathy	1.36e-05	0.000341	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—ITGB1—dilated cardiomyopathy	1.34e-05	0.000336	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—EGFR—dilated cardiomyopathy	1.32e-05	0.000332	CbGpPWpGaD
Phenytoin—SCN5A—Developmental Biology—TNF—dilated cardiomyopathy	1.26e-05	0.000316	CbGpPWpGaD
Phenytoin—ABCC2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	1.15e-05	0.000289	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—GPX1—dilated cardiomyopathy	1.15e-05	0.000288	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—CD36—dilated cardiomyopathy	1.14e-05	0.000286	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—CD36—dilated cardiomyopathy	1.12e-05	0.00028	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	1.11e-05	0.000279	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—RAC1—dilated cardiomyopathy	1.07e-05	0.00027	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.07e-05	0.000269	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	1.07e-05	0.000268	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.04e-05	0.000262	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	1.04e-05	0.000262	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	1.04e-05	0.000261	CbGpPWpGaD
Phenytoin—CYP2C18—Metabolism—AGT—dilated cardiomyopathy	1.01e-05	0.000253	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	9.57e-06	0.00024	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	9.43e-06	0.000237	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	9.4e-06	0.000236	CbGpPWpGaD
Phenytoin—ALB—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	9.34e-06	0.000235	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	9.33e-06	0.000234	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	9.32e-06	0.000234	CbGpPWpGaD
Phenytoin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	8.89e-06	0.000223	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	8.72e-06	0.000219	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	8.49e-06	0.000213	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	8.39e-06	0.000211	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	7.65e-06	0.000192	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—GPX1—dilated cardiomyopathy	7.62e-06	0.000191	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—CD36—dilated cardiomyopathy	7.42e-06	0.000186	CbGpPWpGaD
Phenytoin—ALB—Hemostasis—RAF1—dilated cardiomyopathy	7.12e-06	0.000179	CbGpPWpGaD
Phenytoin—CYP3A7—Metabolism—AGT—dilated cardiomyopathy	6.68e-06	0.000168	CbGpPWpGaD
Phenytoin—ALB—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	6.17e-06	0.000155	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—GPX1—dilated cardiomyopathy	5.64e-06	0.000142	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	5.51e-06	0.000138	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—CD36—dilated cardiomyopathy	5.49e-06	0.000138	CbGpPWpGaD
Phenytoin—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	5.4e-06	0.000136	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	5.37e-06	0.000135	CbGpPWpGaD
Phenytoin—CYP2B6—Metabolism—AGT—dilated cardiomyopathy	4.94e-06	0.000124	CbGpPWpGaD
Phenytoin—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	4.83e-06	0.000121	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	4.77e-06	0.00012	CbGpPWpGaD
Phenytoin—ALB—Metabolism—GPX1—dilated cardiomyopathy	4.75e-06	0.000119	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	4.65e-06	0.000117	CbGpPWpGaD
Phenytoin—ALB—Metabolism—CD36—dilated cardiomyopathy	4.62e-06	0.000116	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—GPX1—dilated cardiomyopathy	4.26e-06	0.000107	CbGpPWpGaD
Phenytoin—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	4.19e-06	0.000105	CbGpPWpGaD
Phenytoin—ALB—Metabolism—AGT—dilated cardiomyopathy	4.16e-06	0.000105	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	4.16e-06	0.000104	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—CD36—dilated cardiomyopathy	4.15e-06	0.000104	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—CD36—dilated cardiomyopathy	4.05e-06	0.000102	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	3.88e-06	9.76e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	3.78e-06	9.5e-05	CbGpPWpGaD
Phenytoin—CYP2C19—Metabolism—AGT—dilated cardiomyopathy	3.74e-06	9.38e-05	CbGpPWpGaD
Phenytoin—ABCB1—Metabolism—AGT—dilated cardiomyopathy	3.65e-06	9.16e-05	CbGpPWpGaD
Phenytoin—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	3.41e-06	8.56e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	2.56e-06	6.43e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	2.49e-06	6.27e-05	CbGpPWpGaD
Phenytoin—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	2.25e-06	5.64e-05	CbGpPWpGaD
